Tuesday, March 31, 2009
FDA approves Novartis drug that slows tumour growth in kidney cancer
WASHINGTON - A drug from Novartis has won U.S. approval as a treatment for patients with kidney cancer that has returned after treatment with older drugs....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment